The interest in SNOA's short activity is a relevant point for discussion. Analyzing the current data from Fintel provides a quantitative perspective on its short profile.
As of the latest available data, Sonoma Pharmaceuticals, Inc. (SNOA) shows a relatively low short interest. The official NASDAQ-supplied short interest stands at 49,733 shares. This translates to a Short Interest % Float of 3.07%.1 The Days to Cover, which indicates how many days it would take for short sellers to cover their positions given the average daily trading volume, is 1.29 days.1 These metrics suggest that SNOA is not currently a heavily shorted stock, and the immediate pressure for a short squeeze based purely on these numbers appears limited.
However, it's worth noting the off-exchange short volume. Fintel data indicates that SNOA has an Off-Exchange Short Volume of 4,665 shares, with an Off-Exchange Short Volume Ratio of 27.36%.1 This figure represents the short volume occurring outside of traditional exchanges, often in dark pools, and can provide additional insights into short-selling activity.
From an institutional ownership perspective, SNOA has 18 institutional owners, all holding long positions. These institutions collectively hold 47,093 shares, representing 2.87% of the institutional shares (excluding 13D/G filings). Notably, there was a significant increase of 60.07% in institutional shares during the most recent quarter.2 While institutional ownership is present, the overall percentage is still modest.
For those looking to delve deeper, Fintel's platform offers comprehensive tools to track short interest, institutional ownership, and short squeeze potential for any stock. You can explore the detailed short interest page for SNOA to monitor daily updates and historical trends.
